UnitedHealth Group Incorporated
$390.86B- Market cap
- $336.83B
- Debt
- +$78.39B
- Cash
- −$24.37B
Capital structure 81% equity / 19% debt · EV / Revenue 0.87x · EV proxy / EBITDA proxy 18.04x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $336.83B · View financials
Snapshot Sep 16, 2026, 4:00 PM ET
Decision snapshot: UNH stock price vs OSCR: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at OSCR's multiple
Needs OSCR P/E.
Implied fair value · at UNH's multiple
Needs Annual EPS is negative.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Capital structure 81% equity / 19% debt · EV / Revenue 0.87x · EV proxy / EBITDA proxy 18.04x
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
UnitedHealth Group Incorporated · implied price per share
Bear
$316.48
Base
$378.28
Bull
$461.66
Oscar Health, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe UNH's profitability and quality deserve a premium to OSCR despite OSCR-based P/S model showing -16.7% downside, then hold or accumulate selectively because UNH remains profitable, has better margins, and has far stronger balance-sheet health than OSCR.
UNH trades above OSCR-implied valuation at $414.40 versus an implied price of $345.20, indicating a -16.7% downside on this framework. However, OSCR comparison is distorted because OSCR has negative earnings and EBITDA, so the P/S anchor is more informative than earnings-based multiples here.
Supporting Metrics